Presentation of childhood cancers to a paediatric shared care unit

Jeremy Roskin1, James Diviney2, Vasanta Nanduri1

  • 1Department of Paediatrics, Watford General Hospital, Watford, UK.

Insights

Most children with cancer present via emergency services, not the 2-week pathway. Pediatric cancer diagnosis routes vary by tumor type, with acute presentations being most common.

Area of Science:

  • Pediatric Oncology
  • Cancer Diagnosis Pathways
  • Health Services Research

Background:

  • Understanding patient pathways is crucial for timely cancer diagnosis in children.
  • Shared care oncology units play a role in managing pediatric cancer cases.
  • Existing referral pathways may not be optimal for pediatric oncology.

Purpose of the Study:

  • To delineate the diagnostic pathways for children with cancer presenting to a shared care oncology unit.
  • To compare presentation and diagnosis timelines across different pediatric cancer types.
  • To evaluate the effectiveness of the 2-week pathway in pediatric oncology.

Main Methods:

  • A retrospective cohort study analyzed 93 children aged 0-15 diagnosed with cancer between 2004-2014.
  • Patient pathways from initial symptoms to diagnosis were mapped.
  • Time to presentation (TTP) and time to diagnosis (TTD) were calculated.

Main Results:

  • Only 2.1% of cases utilized the 2-week pathway; most (67%) presented acutely via general practitioner referral or emergency department.
  • Leukemia predominantly presented acutely via GPs, while solid tumors were more often self-referred to the emergency department.
  • Wilms' tumor had the shortest median TTP (7 days) and TTD (16 days), whereas lymphoma had the longest TTD (120 days).

Conclusions:

  • The majority of pediatric cancer diagnoses occur through acute services, with significant variation based on tumor type.
  • The 2-week pathway appears infrequently used and potentially less relevant for pediatric cancer referrals.
  • Optimizing referral pathways for pediatric oncology requires further investigation into acute presentation patterns.
Abstract

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

2.9K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.8K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K